🎉 M&A multiples are live!
Check it out!

Geovax Labs Valuation Multiples

Discover revenue and EBITDA valuation multiples for Geovax Labs and similar public comparables like CSL, GSK India, and Imugene.

Geovax Labs Overview

About Geovax Labs

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax’s product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.


Founded

1988

HQ

United States of America
Employees

17

Website

geovax.com

Financials

LTM Revenue $5.3M

LTM EBITDA n/a

EV

$9.9M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Geovax Labs Financials

Geovax Labs has a last 12-month revenue of $5.3M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Geovax Labs achieved revenue of $4.0M and an EBITDA of -$24.9M.

Geovax Labs expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Geovax Labs valuation multiples based on analyst estimates

Geovax Labs P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a $4.0M XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$26.7M -$24.9M XXX XXX XXX
EBITDA Margin -Infinity% -629% XXX XXX XXX
Net Profit -$14.0M -$26.0M XXX XXX XXX
Net Margin -Infinity% -657% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Geovax Labs Stock Performance

As of April 15, 2025, Geovax Labs's stock price is $1.

Geovax Labs has current market cap of $11.3M, and EV of $9.9M.

See Geovax Labs trading valuation data

Geovax Labs Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$9.9M $11.3M XXX XXX XXX XXX $-3.82

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Geovax Labs Valuation Multiples

As of April 15, 2025, Geovax Labs has market cap of $11.3M and EV of $9.9M.

Geovax Labs's trades at 1.8x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Geovax Labs's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Geovax Labs and 10K+ public comps

Geovax Labs Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $9.9M XXX XXX XXX
EV/Revenue 2.5x XXX XXX XXX
EV/EBITDA -0.4x XXX XXX XXX
P/E -0.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -0.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Geovax Labs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Geovax Labs Valuation Multiples

Geovax Labs's NTM/LTM revenue growth is 51%

Geovax Labs's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $1.7M for the same period.

Over next 12 months, Geovax Labs's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Geovax Labs's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Geovax Labs and other 10K+ public comps

Geovax Labs Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth Infinity% XXX XXX XXX XXX
EBITDA Margin -629% XXX XXX XXX XXX
EBITDA Growth -7% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -578% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $1.7M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 136% XXX XXX XXX XXX
R&D Expenses to Revenue 600% XXX XXX XXX XXX
Opex to Revenue 736% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Geovax Labs Public Comps

See public comps and valuation multiples for Vaccines & Immunotherapies and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
CSL XXX XXX XXX XXX XXX XXX
Imugene XXX XXX XXX XXX XXX XXX
Prescient Therapeutics XXX XXX XXX XXX XXX XXX
GSK India XXX XXX XXX XXX XXX XXX
AstraZeneca India XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Geovax Labs M&A and Investment Activity

Geovax Labs acquired  XXX companies to date.

Last acquisition by Geovax Labs was  XXXXXXXX, XXXXX XXXXX XXXXXX . Geovax Labs acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Geovax Labs

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Geovax Labs

When was Geovax Labs founded? Geovax Labs was founded in 1988.
Where is Geovax Labs headquartered? Geovax Labs is headquartered in United States of America.
How many employees does Geovax Labs have? As of today, Geovax Labs has 17 employees.
Who is the CEO of Geovax Labs? Geovax Labs's CEO is Mr. David A. Dodd.
Is Geovax Labs publicy listed? Yes, Geovax Labs is a public company listed on NAS.
What is the stock symbol of Geovax Labs? Geovax Labs trades under GOVX ticker.
When did Geovax Labs go public? Geovax Labs went public in 2020.
Who are competitors of Geovax Labs? Similar companies to Geovax Labs include e.g. CSL, Imugene, Prescient Therapeutics, GSK India.
What is the current market cap of Geovax Labs? Geovax Labs's current market cap is $11.3M
What is the current revenue of Geovax Labs? Geovax Labs's last 12-month revenue is $5.3M.
What is the current EV/Revenue multiple of Geovax Labs? Current revenue multiple of Geovax Labs is 1.8x.
Is Geovax Labs profitable? Yes, Geovax Labs is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.